A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH)
Public ClinicalTrials.gov record NCT03976401. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Subjects With Nonalcoholic Steatohepatitis (NASH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study administered for 16 weeks in subjects with biopsy proven F1 - F4 NASH.
Study identification
- NCT ID
- NCT03976401
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 28, 2019 (Actual)
- Primary completion
- Feb 10, 2021 (Actual)
- Completion
- Jan 10, 2022 (Actual)
- Last update posted
- Aug 4, 2022
2019 – 2022
United States locations
- U.S. sites
- 26
- U.S. states
- 9
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Akero Clinical Study Site | Tucson | Arizona | 85711 | — |
| Akero Clinical Study Site | Little Rock | Arkansas | 72117 | — |
| Akero Clinical Study Site | Huntington Park | California | 90255 | — |
| Akero Clinical Study Site | Los Angeles | California | 90036 | — |
| Akero Clinical Study Site | Los Angeles | California | 90057 | — |
| Akero Clinical Study Site | Panorama City | California | 91402 | — |
| Akero Clinical Study Site | Poway | California | 92064 | — |
| Akero Clinical Study Site | Boca Raton | Florida | 33434 | — |
| Akero Clinical Study Site | Lakewood Rch | Florida | 34211 | — |
| Akero Clinical Study Site | Miami | Florida | 33156 | — |
| Akero Clinical Study Site | New Port Richey | Florida | 34653 | — |
| Akero Clinical Study Site | Ocoee | Florida | 34761 | — |
| Akero Clinical Study Site | Port Orange | Florida | 32127 | — |
| Akero Clinical Study Site | Sarasota | Florida | 34240 | — |
| Akero Clinical Study Site | Baton Rouge | Louisiana | 70809 | — |
| Akero Clinical Study Site | Marrero | Louisiana | 70072 | — |
| Akero Clinical Study Site | Kansas City | Missouri | 64131 | — |
| Akero Clinical Study Site | Berlin | New Jersey | 08009 | — |
| Akero Clinical Study Site | Chattanooga | Tennessee | 37421 | — |
| Akero Clinical Study Site | Cedar Park | Texas | 78613 | — |
| Akero Clinical Study Site | Dallas | Texas | 75246 | — |
| Akero Clinical Study Site | Edinburg | Texas | 78539 | — |
| Akero Clinical Study Site | Fort Worth | Texas | 76104 | — |
| Akero Clinical Study Site | San Antonio | Texas | 78215 | — |
| Akero Clinical Study Site | San Antonio | Texas | 78229 | — |
| Akero Clinical Study Site | Webster | Texas | 77598 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03976401, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 4, 2022 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03976401 live on ClinicalTrials.gov.